Published in J Am Coll Cardiol on August 04, 2004
In-hospital Versus After-discharge Complete Revascularization (REVIVA-ST) | NCT04743154
Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med (2006) 8.74
ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12
Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation (2010) 2.89
Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med (2006) 2.55
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. Eur Heart J (2011) 2.40
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation (2009) 2.11
Accuracy of staff-initiated emergency department tracking system timestamps in identifying actual event times. Ann Emerg Med (2008) 1.88
Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging (2010) 1.85
Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med (2008) 1.59
Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults. J Am Geriatr Soc (2012) 1.58
Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy (2008) 1.58
Does hospital performance on process measures directly measure high quality care or is it a marker of unmeasured care? Health Serv Res (2007) 1.49
Indicators of quality of care for patients with acute myocardial infarction. CMAJ (2008) 1.46
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf (2008) 1.45
Disparities in patients presenting to the emergency department with potential acute coronary syndrome: it matters if you are Black or White. Heart Lung (2014) 1.41
Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord (2006) 1.35
Contemporary management of pregnancy-related coronary artery dissection: A single-centre experience and literature review. Exp Clin Cardiol (2009) 1.23
Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian Registry. Indian Heart J (2013) 1.15
Long-term medication adherence after myocardial infarction: experience of a community. Am J Med (2009) 1.14
Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study. J Gen Intern Med (2008) 1.04
Delay in presentation and reperfusion therapy in ST-elevation myocardial infarction. Am J Med (2008) 1.04
Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med (2008) 1.01
Pharmacologic agents for acute hemodynamic instability: Recent advances in the management of perioperative shock- A systematic review. Ann Card Anaesth (2015) 1.01
Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement. Can J Cardiol (2007) 1.00
Regionalization of ST-segment elevation acute coronary syndromes care: putting a national policy in proper perspective. J Am Coll Cardiol (2006) 0.98
Contemporary trends in evidence-based treatment for acute myocardial infarction. Am J Med (2010) 0.97
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights. Circ Cardiovasc Qual Outcomes (2012) 0.97
Financial stress and outcomes after acute myocardial infarction. PLoS One (2012) 0.95
Fibrinolytic Therapy in CCU Instead of Emergency Ward: How It Affects Door to Needle Time? Int J Prev Med (2014) 0.94
Nitroglycerin use in myocardial infarction patients. Circ J (2011) 0.93
ST-segment elevation: Distinguishing ST elevation myocardial infarction from ST elevation secondary to nonischemic etiologies. World J Cardiol (2014) 0.93
Acute coronary syndromes: Diagnosis and management, part II. Mayo Clin Proc (2009) 0.93
Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction. Am Heart J (2012) 0.92
Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol (2007) 0.92
Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92
Timing, setting and incidence of cardiovascular complications in patients with acute myocardial infarction submitted to primary percutaneous coronary intervention. Can J Cardiol (2006) 0.92
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J (2008) 0.92
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart (2007) 0.92
Improved microcirculation in patients with an acute ST-elevation myocardial infarction treated with the Impella LP2.5 percutaneous left ventricular assist device. Clin Res Cardiol (2009) 0.91
Changing trends in the evaluation of ejection fraction in patients hospitalized with acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J (2008) 0.90
Canadian quality indicators for percutaneous coronary interventions. Can J Cardiol (2008) 0.90
A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarction. J Gen Intern Med (2008) 0.90
The impact of cardiac and noncardiac comorbidities on the short-term outcomes of patients hospitalized with acute myocardial infarction: a population-based perspective. Clin Epidemiol (2013) 0.90
Exercise training early after acute myocardial infarction reduces stress-induced hypoperfusion and improves left ventricular function. Eur J Nucl Med Mol Imaging (2012) 0.90
Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study. Br J Clin Pharmacol (2008) 0.90
Evolving considerations in the management of patients with left bundle branch block and suspected myocardial infarction. J Am Coll Cardiol (2012) 0.89
Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis. Korean Circ J (2011) 0.89
An update on coronary artery disease and chronic kidney disease. Int J Nephrol (2014) 0.89
Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: an analysis over an 8-year period in a tertiary care centre. Clin Res Cardiol (2010) 0.88
Thrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodeling. J Cardiovasc Magn Reson (2012) 0.88
Improving use of prehospital 12-lead ECG for early identification and treatment of acute coronary syndrome and ST-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 0.88
Validation of the GRACE score for prognosis in Indian patients with acute coronary syndromes. Indian Heart J (2012) 0.87
MR delayed enhancement imaging findings in suspected acute myocarditis. Eur Radiol (2009) 0.87
Posterior myocardial infarction: the dark side of the moon. Neth Heart J (2007) 0.86
Developing practice recommendations for endovascular revascularization for acute ischemic stroke. Neurology (2012) 0.86
Secondary prevention of myocardial infarction with nonpharmacologic strategies in a Medicaid cohort. Prev Chronic Dis (2009) 0.86
Primary angioplasty for any patient with ST-elevation myocardial infarction? Guideline-adherent feasibility and impact on mortality in a rural infarction network. Clin Res Cardiol (2010) 0.86
The door-to-balloon alliance for quality: who joins national collaborative efforts and why? Jt Comm J Qual Patient Saf (2009) 0.86
Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res Cardiol (2012) 0.85
Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel. Biomatter (2013) 0.85
Clinical Toxicities of Histone Deacetylase Inhibitors. Pharmaceuticals (Basel) (2010) 0.85
Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol (2015) 0.85
Successful medical management of a left ventricular thrombus and aneurysm following failed thrombolysis in myocardial infarction. Clin Med Insights Cardiol (2013) 0.84
Reducing Door to- Balloon- Time for Acute ST Elevation Myocardial Infarction In Primary Percutaneous Intervention: Transformation using Robust Performance Improvement. BMJ Qual Improv Rep (2015) 0.83
Korean National Health Insurance value incentive program: achievements and future directions. J Prev Med Public Health (2012) 0.83
Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model. BMC Cardiovasc Disord (2010) 0.82
The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients. Exp Clin Cardiol (2009) 0.82
A nonthoracotomy myocardial infarction model in an ovine using autologous platelets. Biomed Res Int (2013) 0.82
Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock. Neth Heart J (2012) 0.82
Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice. Clin Res Cardiol (2008) 0.82
Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry. Clin Res Cardiol (2014) 0.81
Usefulness of the heart-rate variability complex for predicting cardiac mortality after acute myocardial infarction. BMC Cardiovasc Disord (2014) 0.80
Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin. Cardiovasc Drugs Ther (2010) 0.80
Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007. BMC Res Notes (2012) 0.79
Left main coronary artery occlusion with myocardial infarction in a cocaine user. Successful angioplasty with a drug-eluting stent. Can J Cardiol (2008) 0.79
Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction. Atherosclerosis (2009) 0.79
Left bundle branch block and suspected myocardial infarction: does chronicity of the branch block matter? Eur Heart J Acute Cardiovasc Care (2013) 0.79
Comparison of clinical outcomes of Chinese men and women after coronary stenting for coronary artery disease: a multi-center retrospective analysis of 4,334 patients. J Biomed Res (2013) 0.79
Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial). Curr Control Trials Cardiovasc Med (2004) 0.79
Illness cognition as a predictor of exercise habits and participation in cardiac prevention and rehabilitation programs after acute coronary syndrome. BMC Public Health (2013) 0.79
In-hospital daily insulin dose predicts long-term adverse outcome in patients with diabetes with ST-elevation myocardial infarction treated with successful primary percutaneous angioplasty. Arch Med Sci (2014) 0.79
Trends in the Use of Evidence-based Therapies Early in the Course of Acute Myocardial Infarction and its Influence on Short Term Patient Outcomes. Open Cardiovasc Med J (2011) 0.79
Where does the Occluded Artery Trial leave the late open artery hypothesis? Heart (2007) 0.79
Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study). Am J Cardiol (2010) 0.79
TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin Res Cardiol (2008) 0.78
Achieving optimal care for ST-segment elevation myocardial infarction in Canada. CMAJ (2007) 0.78
Association of matrix Gla protein gene allelic polymorphisms (G(-7)→A, T(-138)→C and Thr(83)→Ala) with acute coronary syndrome in the Ukrainian population. Exp Clin Cardiol (2012) 0.78
Craniofacial Pain as the Sole Sign of Prodromal Angina and Acute Coronary Syndrome: A Review and Report of a Rare Case. Iran Endod J (2015) 0.78
Trends in myocardial infarction rates and case fatality by anatomical location in four United States communities, 1987 to 2008 (from the Atherosclerosis Risk in Communities Study). Am J Cardiol (2013) 0.78
Unprotected left main coronary artery intervention for acute myocardial infarction and cardiogenic shock. Tex Heart Inst J (2007) 0.78
β-Blockers in coronary artery disease management. Hippokratia (2010) 0.77
Pain to hospital times after myocardial infarction in patients from Dalmatian mainland and islands, southern Croatia. Croat Med J (2010) 0.77
Medication Management Among Medicaid Myocardial Infarction Survivors. Wash State J Public Health Pract (2008) 0.77
Improving door-to-balloon time by decreasing door-to-ECG time for walk-in STEMI patients. West J Emerg Med (2014) 0.77
Postconditioning in man. Heart Fail Rev (2007) 0.77
Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome. Am J Cardiol (2009) 0.77
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA (2005) 5.83
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 4.67
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol (2002) 4.48
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med (2007) 3.40
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation (2012) 3.38
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
Training cardiovascular fellows in cardiovascular magnetic resonance and vascular imaging; Current status following the core cardiovascular training symposium (COCATS-2) guidelines. J Am Coll Cardiol (2004) 2.67
Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging (2009) 2.56
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med (2008) 2.52
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation (2003) 2.52
Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging (2012) 2.50
Neovascularization in human atherosclerosis. Circulation (2006) 2.44
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology (2010) 2.43
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol (2007) 2.32
OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging (2013) 2.31